Search:
This item requires a subscription.
Management of relapsed histologically aggressive non-Hodgkin’s lymphoma BJCM, Volume 2, Number 1.
Non-Hodgkin’s lymphoma (NHL) is becoming increasingly common, with 9,000 cases in the UK and over a quarter of a million cases diagnosed worldwide per annum.1 Approximately 60% are histologically aggressive lymphomas amounting to around 5,000 new cases/year in the UK. Their incidence increases markedly with age, rising from 0.4 per 100,000 in the 20–24 year age group to 16 per 100,000 in the over-75s; the median age at presentation is around 60.2
To view this item, select one of the options below:
Purchase access
Sign in
email address
Password
Important
All the articles are in PDF format.
To view the articles you will need Adobe Acrobat Reader.
To download a copy, free of charge, please click here.